Novartis India Profit & Loss Annual

Trade
BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | Sector: Biotechnology & Drugs
1,028.20 +2.40 (0.23%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 335.07378.74399.87381.35
Total Revenue 335.07378.74399.87381.35
Costof Revenue Total 199.84204.62181.47149.63
Gross Profit 135.23174.12218.40231.72
Selling/ General/ Admin Expenses Total 23.1397.05188.65197.10
Depreciation/ Amortization 2.616.069.6512.16
Other Operating Expenses Total 46.8410.932.507.69
Total Operating Expense 272.42318.66431.91366.58
Operating Income 62.6560.08-32.0414.77
Interest Inc( Exp) Net- Non- Op Total -14.90516.00161.70175.70
Other Net 61.680.8112.193.15
Net Income Before Taxes 122.84115.38-3.8240.04
Provisionfor Income Taxes 37.6512.02-0.1019.14
Net Income After Taxes 85.19103.36-3.7220.90
Net Income Before Extra Items 85.19103.36-3.7220.90
Net Income 85.19103.36-3.7220.90
Income Availableto Com Excl Extra Ord 85.19103.36-3.7220.90
Income Availableto Com Incl Extra Ord 85.19103.36-3.7220.90
Diluted Net Income 85.19103.36-3.7220.90
Diluted Weighted Average Shares 2.472.472.472.47
Diluted EPS Excluding Extra Ord Items 34.5041.86-1.518.46
DPS- Common Stock Primary Issue 25.0010.0010.0010.00
Diluted Normalized EPS 34.5040.8111.607.50
Unusual Expense( Income) -0.0049.64-
Gain( Loss)on Saleof Assets -28.90-1.4045.50
Total Extraordinary Items ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts